Abstract
Significantly higher pharyngeal shedding of Epstein-Barr virus (EBV) is observed during HIV infection. Increased EBV shedding in pharynx is not affected even during highly active antiretroviral theyrapy (HAART). EBV positive monocyte populations have been shown to carry EBV to pharyngeal mucosa. Human cytokine profiles are often altered to facilitate herpes virus infection. Thus pharyngeal cytokine profiles may influence EBV reactivation and shedding during HIV infection. Our objective was to compare 37 pharyngeal cytokine profiles of HIV-seropositive patients who were or were not receiving HAART therapy.
Document Type
Presentation
Publication Date
1-10-2011
Digital Object Identifier (DOI)
http://dx.doi.org/10.1186/1753-6561-5-S1-P90
Repository Citation
Perera, R. A. P. M.; Tsang, P. C. S.; Miller, Craig S.; Li, P.; Lee, M. P.; and Samaranayake, L. P., "Identification of differential pharyngeal cytokine profiles during HIV infection" (2011). Center for Oral Health Research Presentations. 1.
https://uknowledge.uky.edu/cohr_present/1
Notes/Citation Information
A presentation at the Institut Pasteur International Network Annual Scientific Meeting in Hong Kong, China in November 22-23, 2010.
Published in BMC Proceedings, v. 5 (Suppl. 1): P90.
© 2011 Perera et al; licensee BioMed Central Ltd.
This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.